Keli Walbert

Insider Reports History

Entity
Individual
Location
C/O Apellis Pharmaceuticals, Inc., 100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Keli Walbert
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keli Walbert:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 15.4K $508K $33.00 Jan 8, 2025 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 9.09K $307K $33.81 Jan 8, 2025 Direct

Insider Reports Filed by Keli Walbert

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 8, 2025 2 $508K 4 Jan 10, 2025 Director
APLS Apellis Pharmaceuticals, Inc. Jan 8, 2025 0 $0 3 Jan 10, 2025 Director